CVE-2026-22237
Blusparkglobal Bluvoyix information disclosure
- Published14 Jan 2026
Description
The vulnerability exists in BLUVOYIX due to the exposure of sensitive internal API documentation. An unauthenticated remote attacker could exploit this vulnerability by sending specially crafted HTTP requests to the APIs exposed by the documentation. Successful exploitation of this vulnerability could allow the attacker to cause damage to the targeted platform by abusing internal functionality.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2026-22237 being actively exploited?
CVE-2026-22237 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.48%.
How severe is CVE-2026-22237?
CVE-2026-22237 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.48% probability of exploitation.
Which products are affected by CVE-2026-22237?
Affected products include Blusparkglobal Bluvoyix.
How do I fix CVE-2026-22237?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2026-22237 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.